Decrease in Immune Activation in HIV-Infected Patients Treated with Highly Active Antiretroviral Therapy Correlates with the Function of Hematopoietic Progenitor Cells and the Number of Niave CD4⁺ Cells

REFERENCES

• Autran B, Carcelain G, Li TS, et al. Positive effect of combined antiretroviral therapy on CD4 + T cell homeostasis and function in advanced HIV disease. Science 1997; 277: 112–6.
   PubMed Web of Science ®Google Scholar
• Bisset LR, Cone RW, Huber W, et al. Highly active antiretroviral therapy during early HIV infection reverses T cell activation and maturation abnormalities. AIDS 1998; 12: 2115–23.
   PubMedGoogle Scholar
• Giorgi JV, Majchrowicz MA, Johnson TD, Hultin P, Matud J, Detels R. Immunological effects of combined protease inhibitor and reverse transcriptase inhibitor therapy in previously treated chronic HIV-1 infection. AIDS 1998; 12: 1833–44.
   PubMed Web of Science ®Google Scholar
• Pakker NG, Notermans DW, de Boer RJ, et al. Biphasic kinetics of peripheral blood T cells after triple combination therapy in HIV-1 infection: a composite of redistribution and proliferation. Nat Med 1998; 4: 208–14.
   PubMed Web of Science ®Google Scholar
• Wei X, Ghosh SK, Taylor ME, et al. Viral dynamics in human immunodeficiency virus type 1 infection. Nature 1995; 373: 117–22.
   PubMed Web of Science ®Google Scholar
• Roederer M, Raju PA, Mitra DK, Herzenberg LA, Herzenberg LA. HIV does not replicate in naive CD4 cells stimulated with CD3/CD28. J Clin Invest 1997; 99: 1555–64.
   PubMedGoogle Scholar
• Bagnara GP, Zauli G, Giovannini M, Re MC, Furlini G, La Placa M. Early loss of circulating hemopoietic progenitors in HIV-1-infected subjects. Exp Hematol 1990; 18: 426–30.
   Google Scholar
• Clark DR, Repping S, Pakker NG, et al. T cell progenitor function during progressive HIV-1 infection and after antiretroviral therapy. Blood (in press).
   Google Scholar
• De Luca A, Teofili L, Antinori A, et al. Haemopoietic CD34 + progenitor cells are not infected by HIV-1 in vivo but show impaired clonogenesis. Br J Haematol 1993; 85: 20–4.
   PubMedGoogle Scholar
• Louache F, Henri A, Bettaieb A, et al. Role of human immunodeficiency virus replication in defective in vitro growth of hematopoietic progenitors. Blood 1992; 80: 2991–9.
   PubMed Web of Science ®Google Scholar
• Nielsen SD, Ersbøll AK, Mathiesen L, Nielsen JO, Hansen JES. Highly active antiretroviral therapy normalizes the function of progenitor cells in human immunodeficiency virus-infected patients. J Infect Dis 1998; 178: 1299–305.
   PubMed Web of Science ®Google Scholar
• Re MC, Zauli G, Furlini G, et al. The impaired number of circulating granulocyte/macrophage progenitors (CFU-GM) in human immunodeficiency virus-type 1 infected subjects correlates with an active HIV-1 replication. Arch Virol 1993; 129: 53–64.
   PubMedGoogle Scholar
• Zauli G, Re MC, Visani G, et al. Evidence for a human immunodeficiency virus type 1-mediated suppression of uninfected hematopoietic (CD34 + ) cells in AIDS patients. J Infect Dis 1992; 166: 710–6.
   PubMed Web of Science ®Google Scholar
• Connors M, Kovacs JA, Krevat S, et al. HIV infection induces changes in CD4 + T cell phenotype and depletions within the CD4 + T cell repertoire that are not immediately restored by antiviral or immune-based therapies. Nat Med 1997; 3: 533–40.
   PubMed Web of Science ®Google Scholar
• Evans TG, Bonnez W, Soucier HR, Fitzgerald T, Gibbons DC, Reichman RC. Highly active antiretroviral therapy results in a decrease in CD8+ T cell activation and preferential reconstitution of the peripheral CD4 + T cell population with memory rather than naive cells. Antiviral Res 1998; 39: 163–73.
   PubMedGoogle Scholar
• Kelleher AD, Carr A, Zaunders J, Cooper DA. Alterations in the immune response of human immunodeficiency virus (HIV)-infected subjects treated with an HIV-specific protease inhibitor, ritonavir. J Infect Dis 1996; 173: 321–9.
   PubMed Web of Science ®Google Scholar
• Benito JM, Zabay JM, Gil J, et al. Quantitative alterations of the functionally distinct subsets of CD4 and CD8 lymphocytes in asymptomatic HIV infection: changes in the expression of CD45RO, CD45RA; CD11b, CD38, HLA-DR, and CD25 antigens. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14: 128–35.
   PubMedGoogle Scholar
• Bouscarat F, Levacher-Clergeot M, Dazza MC, et al. Correlation of CD8 lymphocyte activation with cellular viremia and plasma HIV RNA levels in asymptomatic patients infected by human immunodeficiency virus type 1. AIDS Res Hum Retro 1996; 12: 17–24.
   PubMed Web of Science ®Google Scholar
• Bouscarat F, Levacher M, Landman R, et al. Changes in blood CD8 + lymphocyte activation status and plasma HIV RNA levels during antiretroviral therapy. AIDS 1998; 12: 1267–73.
   PubMedGoogle Scholar
• Giorgi JV, Liu Z, Hultin LE, Cumberland WG, Hennessey K, Detels R. Elevated levels of CD38 + CD8 + T cells in HIV infection add to the prognostic value of low CD4+ T cell levels: results of 6 years of follow-up. J Acquir Immune Defic Syndr Hum Retrovirol 1993; 6: 904–12.
   Google Scholar
• Giorgi JV, Hultin LE, McKeating JA, et al. Shorter survival in advanced human immunodeficiency virus type 1 infection is more closely associated with T lymphocyte activation than with plasma virus burden or virus chemokine coreceptor usage. J Infect Dis 1999; 179: 859–70.
   PubMed Web of Science ®Google Scholar
• Liu Z, Hultin LE, Cumberland WG, et al. Elevated relative flourescence intensity of CD38 antigen expression on CD8 + T cells is a marker of poor prognosis in HIV infection: Results of 6 years of follow-up. Cytometry 1996; 26: 1–7.
   PubMedGoogle Scholar
• Liu Z, Cumberland WG, Hultin LE, et al. Elevated CD38 antigen expression on CD8 + T cells is a stronger marker for the risk of chronic HIV disease progression to AIDS and death in the multicenter AIDS cohort study than CD4 + cell count, soluble immune activation markers, or combinations of HLA-DR and CD38 expression. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 16: 83–92.
   PubMedGoogle Scholar
• Orendi JM, Bloem AC, Borleffs JC, et al. Activation and cell cycle antigens on CD4+ and CD8+ T cell correlate with plasma human immunodeficiency virus (HIV-1) RNA levels in HIV-1 infection. J Infect Dis 1998; 178: 1279–87.
   PubMedGoogle Scholar
• Prince HE, Jensen ER. Three-color cytoflourometric analysis of CD8 cell subsets in HIV-1 infection. J Acquir Immune Defic Syndr Hum Retrovirol 1991; 4: 1227–32.
   Google Scholar
• Gougeon ML, Lecoeur H, Dulioust A, et al. Programmed cell death in peripheral lymphocytes from HIV-infected persons. J Immunol 1996; 156: 3509–20.
   PubMed Web of Science ®Google Scholar
• Johnson N, Parkin JM. Anti-retroviral therapy reverses HIV-associated abnormalities in lymphocyte apoptosis. Clin Exp Immunol 1998; 113: 229–34.
   PubMed Web of Science ®Google Scholar
• Karmochkine M, Parizot C, Calvez V, et al. Susceptibility of peripheral blood mononuclear cells to apoptosis is correlated to plasma HIV load. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17: 419–23.
   PubMedGoogle Scholar
• Meyaard L, Otto SA, Jonker RR, Mijnster MJ, Keet RP, Miedema F. Programmed death of T cells in HIV-1 infection. Science 1992; 257: 217–9.
   PubMed Web of Science ®Google Scholar
• Nielsen SD, Afzelius P, Ersbøll AK, Nielsen JO, Hansen JES. Expression of the activation antigens CD69 reflects post-expansion functionality of PBMC from healthy donors and HIV-infected patients. Clin Exp Immunol 1998; 114: 66–72.
   Google Scholar
• Clerici M, Shearer GM. A Th1 to Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 1993; 14: 107–14.
   PubMedGoogle Scholar
• Clerici M, Hakim FT, Venzon DJ, et al. Changes in interleukin-2 and interleukin-4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J Clin Invest 1993; 91: 759–65.
   PubMed Web of Science ®Google Scholar
• Klein SA, Dobmeyer JM, Dobmeyer TS, et al. Demonstration of the Th1 to Th2 cytokine shift during the course of HIV-1 infection using cytoplasmic cytokine detection on single cell level by flow cytometry. AIDS 1997; 11: 1111–8.
   PubMed Web of Science ®Google Scholar
• Meyaard L, Hovenkamp E, Keet IMP, et al. Single-cell analysis of IL-4 and IFN-γ production by T cells from HIV-infected individuals. J Immunol 1996; 157: 2712–8.
   PubMedGoogle Scholar
• Graziosi C, Pantaleo G, Gantt KR, et al. Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals. Science 1994; 265: 248–52.
   PubMed Web of Science ®Google Scholar
• Maggi E, Mazzetti M, Ravina A, et al. Ability of HIV to promote a Th1 to Th0 shift and to replicate preferentially in Th2 and Th0 cells. Science 1994; 265: 244–8.
   PubMed Web of Science ®Google Scholar
• Sousa AE, Victorino RMM. Single-cell analysis of lymphokine imbalance in asymptomatic HIV-1 infection: Evidence for a major alteration within the CD8+ T cell subset. Clin Exp Immunol 1998; 112: 294–302.
   PubMedGoogle Scholar
• Crowder MJ, Hand DJ. Analysis of repeated measurements. London: Chapman & Hall, 1990: 257.
   Google Scholar
• O’Brien WA, Hartigan PM, Martin D, et al. Changes in plasma HIV-1 RNA and CD4⁺ lymphocyte counts and the risk of progression to AIDS. N Engl J Med 1996; 334: 426–31.
   Google Scholar
• Ullum H, Lepri AC, Victor J, Skinhøj P, Phillips AN, Pedersen BK. Increased losses of CD4 CD45RA⁺ cells in late stages of HIV infection is related to increased risk of death: evidence from a cohort of 347 HIV-infected individuals. AIDS 1997; 12: 1479–85.
   Google Scholar
• Cozzi Lepri A, Katzenstein TL, Ullum H, et al. The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection. AIDS 1998; 12: 1639–43.
   PubMed Web of Science ®Google Scholar
• Andersson J, Fehniger TE, Patterson BK, et al. Early reduction of immune activation in lymphoid tissue following highly active HIV therapy. AIDS 1998; 12: F123–9.
   PubMedGoogle Scholar